(August 25, 2016, 1:12 PM EDT) -- TULSA, Okla. — Genentech Inc. on Aug. 23 moved for summary judgment in the Herceptin vial multidistrict litigation, arguing that plaintiff claims that vials were underfilled are preempted by federal law (In Re: Genentech, Inc., Herceptin [Trastuzumab] Marketing and Sales Practices Litigation, MDL Docket No. 2700, No.16-md-2700, N.D. Okla.)....